Comprehensive Analysis of 50 Oncology Franchises Globally
NEW PROGRAM
This new program offers detailed analysis of virtually all significant players in the global oncology marketplace. The study covers a full-range of oncology franchises, including:
 | Industry leaders |
| Single product niche players |
| Up-and-coming biotechs |
| Emerging big pharma franchises |
Detailed assessments of each organization are provided, including:
| Current product portfolio |
| Oncology pipeline |
| Key agreements/alliances |
| Sales and marketing capabilities |
| Research and clinical development capabilities |
| Financial resources |
| Strengths and weaknesses |
| Future outlook |
* Save 5% -- Mention "PharmCast.com" when purchase.
To receive more information about the study, including a list of companies analyzed and sample pages, click on the "Request for Info" link.
 |
 |
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |